Market News
Stay updated with the latest market trends, earnings, and economic indicators.

SEBI proposes review of AMC executive remuneration disclosure norms
SEBI seeks public comments on proposed changes to AMC executive pay disclosures, aiming to streamline norms while preserving transparency for mutual fund investments.

Axis MF's Shreyash Devalkar sees opportunities in EVs, exports and FMCG recovery
Shreyash Devalkar, Head of Equity at Axis Mutual Fund, highlighted rising electric vehicle adoption in two-wheelers and said manufacturing exporters could emerge as beneficiaries of rupee depreciation over time. Devalkar also remains selective on consumption plays and cautious on large-cap IT stocks due to weak growth visibility.

Gold ETFs Break 13-Month Win Streak As Investors Pull Out Rs 725 Crore In May
Net gold ETF outflows stood at Rs 725 crore, according to data released by the Association of Mutual Funds in India

Nifty 500 Q4 Review: HDFC Bank, Indian Oil, Tata Motors Among Top Winners, Losers; Key Sector Trend — Read Motilal Oswal's Report
Of the 23 key sectors, 14 posted double-digit profit growth in Q4 FY26.
India equity mutual fund inflows slip to one-year low in May amid Iran war jitters, AMFI data - Reuters
India equity mutual fund inflows slip to one-year low in May amid Iran war jitters, AMFI dataReuters

Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal — Check Target Price
Glenmark Pharma's shares are likely to remain in focus after Motilal Oswal has reiterated its positive stance on the stock.

ICICI Lombard: AI Integration Lifts Growth Outlook — Buy, Sell or Hold? Read Motilal Oswal's Analysis
Leadership in motor insurance, accelerating momentum in retail health, expanding distribution capabilities, growing AI integration and a strong balance sheet remains ICICI Lombard's key growth drivers.

Cummins India Stock in Focus: Motilal Oswal Bullish on Growth Outlook — Check Target Price
Motilal Oswal expects Cummins overall Ebitda margin to remain strong on a healthy revenue mix despite higher raw material prices, which are currently passed through to clients.

Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By Reuters - Investing.com
Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By ReutersInvesting.com
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.